Publication
Idarubicin versus daunorubicin versus mitoxantrone for induction chemotherapy in acute myeloid leukemia: patient registration study of Turkish Society of Hematology-Acute …
01 Ocak 2023
Makale
Google Scholar
Authors
Atıf kopyala
P. M. KAÇMAZ (2023). Idarubicin versus daunorubicin versus mitoxantrone for induction chemotherapy in acute myeloid leukemia: patient registration study of Turkish Society of Hematology-Acute …. *Blood 142 (Supplement 1), 5838-5838, 2023*.
Yayın bilgileri
Dergi
Blood 142 (Supplement 1), 5838-5838, 2023
Veri tabanı
Google Scholar
Kaynak
GoogleScholar
Atıf verisi 14 Kasım 2026 tarihinde güncellendi.
IE Pinar, S Celik, MG Polat, AF Karatas, A Dogan, U Iltar, G Cengiz Seval, ... | Blood 142 (Supplement 1), 5838-5838, 2023
Citations by source
| Kaynak | Atıf |
|---|---|
| Google Scholar | 4 |
| Etkin | 0 |
Yayın metrikleri (GS / WoS / Scopus)
GS
4
Google Scholar Atıf
Other publications by authors
Other academic outputs by the same KKU authors — newest first.
İlgili yayınlar yükleniyor…
İlgili yayın bulunamadı.
